Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi’s Laboratories has informed that it enclosed the schedule of Earnings Conference Call for Q2FY22 to be held on November 06, 2021.
The above information is a part of company’s filings submitted to BSE.